Clinical Trials Browser

Phase 3 × telaprevir × Clear all

NCT01821963 2020-09-24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1 enrolled 3 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Infections